Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for the asymmetric synthesis of (2s,3r)-p-thiamphenylphenylserine in whole cells with "multiple enzymes in one bacterium"

A technology of thiamphenylphenylserine and whole cells, which is applied in the fields of biocatalysis and enzyme engineering, can solve the problems of low yield of target products, lack of short reaction time, cumbersome and time-consuming operations, etc., so as to save the fermentation production and purification preparation process , It is beneficial to industrial production and application, and the effect of reducing production costs

Active Publication Date: 2021-07-30
福建昌生生物科技发展有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the reaction route is simple and suitable for industrial production, there are the following problems: 1. The reaction conditions are severe, and strong acid and strong base are used simultaneously; 2. The expensive chiral resolution reagent D-tartaric acid is required
The operation is cumbersome and time-consuming, the production cost is high, and the method adopts the method of chiral resolution instead of the asymmetric catalytic synthesis method, and the yield of the target product is low, only 50%
[0008] Therefore, there is a lack of a high-efficiency synthesis technology of (2S,3R)-p-thiamphenicol phenylserine that is easy to operate, short in reaction time, does not require enzyme fermentation production and purification preparation process, and is more conducive to industrial production and application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for the asymmetric synthesis of (2s,3r)-p-thiamphenylphenylserine in whole cells with "multiple enzymes in one bacterium"
  • Method for the asymmetric synthesis of (2s,3r)-p-thiamphenylphenylserine in whole cells with "multiple enzymes in one bacterium"
  • Method for the asymmetric synthesis of (2s,3r)-p-thiamphenylphenylserine in whole cells with "multiple enzymes in one bacterium"

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] Preferred embodiments of the present invention are provided below to help further understanding of the present invention. Those skilled in the art should understand that the descriptions of the embodiments of the present invention are only exemplary, and are not intended to limit the solution of the present invention.

[0025] "One bacterium multi-enzyme" method for the asymmetric synthesis of (2S,3R)-p-thiamphenylphenylserine in whole cells, prepared by the following method: Step 1: Construction of double-plasmid engineering bacteria

[0026] L-threonine transaldolase is encoded by the gene PsLTTA, and the recombinant expression plasmid pET28a-PsLTTA is constructed; alcohol dehydrogenase and formate dehydrogenase are encoded by the genes ApADH and CbFDH, respectively, and the recombinant expression plasmid pETDuet-ApADH / CbFDH is constructed; the recombinant Transform Escherichia coli BL21(DE3) with expression plasmids pETDuet-ApADH / CbFDH and pET28a-PsLTTA to construct ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for asymmetrically synthesizing (2S, 3R)-p-thiamphenicol phenylserine in whole cells with "one bacterium and multiple enzymes", which belongs to the field of biocatalysis and enzyme engineering. By simultaneously expressing L-threonine transaldolase (PsLTTA), alcohol dehydrogenase (ApADH) and formate dehydrogenase (CbFDH) in E. Asymmetric and efficient biosynthesis of sulfonylphenylserine. The present invention can obtain the key chiral building block (2S, 3R)-p-thiamphenicol-phenylserine of β-aminoalcohol antibiotics through one-step reaction under normal temperature and pressure, and at the same time remove the inhibitory effect of by-product acetaldehyde on PsLTTA , is an efficient green biosynthetic pathway.

Description

technical field [0001] The invention belongs to the field of biocatalysis and enzyme engineering, and specifically relates to a method for asymmetrically synthesizing (2S, 3R)-p-thiamphenicol phenylserine in whole cells with "one bacterium and multiple enzymes". Background technique [0002] (2S,3R)-P-thymphenylphenylserine is a key chiral building block for the synthesis of β-aminoalcohol antibiotics florfenicol and thiamphenicol. In 2015, China’s export volume of β-aminoalcohol antibiotics alone exceeded 2,700 tons, a year-on-year increase of 9.2%, and the export value reached 186 million US dollars, ranking among my country’s top 10 export drugs. Therefore, the establishment of a fast, efficient and green synthetic route to (2S,3R)-p-thymphenylphenylserine has broad application prospects. [0003] At present, the main method of large-scale production of (2S,3R)-p-thiamphenicol phenylserine at home and abroad is to use p-thiamphenicol benzaldehyde and glycine as raw mater...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12P13/04C12N1/21C12R1/19
CPCC12N9/0006C12N9/0008C12N9/1022C12P13/04C12Y101/01001C12Y102/01002C12Y202/01
Inventor 林娟许炼许鑫琦王力超赖凌燕陈承滔
Owner 福建昌生生物科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products